Latest filings (excl ownership)
EFFECT
Notice of effectiveness
31 Mar 17
EFFECT
Notice of effectiveness
31 Mar 17
15-12G
Securities registration termination
30 Mar 17
POS AM
Prospectus update (post-effective amendment)
28 Mar 17
POS AM
Prospectus update (post-effective amendment)
28 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Mar 17
DEF 14A
Definitive proxy
18 Nov 16
10-Q
2016 Q3
Quarterly report
14 Nov 16
424B3
Prospectus supplement
4 Nov 16
PRE 14A
Preliminary proxy
4 Nov 16
EFFECT
Notice of effectiveness
3 Nov 16
CORRESP
Correspondence with SEC
31 Oct 16
UPLOAD
Letter from SEC
24 Oct 16
S-1
IPO registration
12 Oct 16
D
$4.51M in equity / options / securities to be acquired, sold $4.51M, 15 investors
30 Aug 16
10-Q
2016 Q2
Quarterly report
22 Aug 16
8-K
Entry into a Material Definitive Agreement
16 Aug 16
NT 10-Q
Notice of late quarterly filing
16 Aug 16
10-Q
2016 Q1
Quarterly report
16 May 16
424B3
Prospectus supplement
19 Apr 16
EFFECT
Notice of effectiveness
18 Apr 16
CORRESP
Correspondence with SEC
14 Apr 16
S-1/A
IPO registration (amended)
1 Apr 16
10-K
2015 FY
Annual report
30 Mar 16
UPLOAD
Letter from SEC
29 Mar 16
CT ORDER
Confidential treatment order
24 Mar 16
8-K
Departure of Directors or Certain Officers
17 Mar 16
S-1
IPO registration
11 Mar 16
8-K
Entry into a Material Definitive Agreement
13 Jan 16
10-Q
2015 Q3
Quarterly report
16 Nov 15
8-K
Entry into a Material Definitive Agreement
26 Oct 15
8-K
Departure of Directors or Certain Officers
11 Sep 15
10-Q
2015 Q2
Quarterly report
14 Aug 15
10-Q
2015 Q1
Quarterly report
15 May 15
10-K
2014 FY
Annual report
31 Mar 15
8-K
Other Events
31 Dec 14
8-K
Departure of Directors or Certain Officers
4 Dec 14
424B3
Prospectus supplement
17 Nov 14
10-Q
2014 Q3
Quarterly report
14 Nov 14
8-K
Other Events
28 Oct 14
Latest ownership filings
SC 13G/A
Arno Therapeutics, Inc
3 Jan 18
SC 13G/A
Arno Therapeutics, Inc
14 Feb 17
SC 13G/A
Arno Therapeutics, Inc
14 Feb 17
SC 13G/A
Arno Therapeutics, Inc
14 Feb 17
3
Jonathan J Zucker
9 Jan 17
SC 13D
Arno Therapeutics, Inc
9 Jan 17
SC 13G/A
Arno Therapeutics, Inc
5 Jan 17
4
S DONALD SUSSMAN
3 Jan 17
SC 13D/A
Arno Therapeutics, Inc
3 Jan 17
4
DAVID M TANEN
5 Oct 16
3/A
S DONALD SUSSMAN
8 Sep 16
3/A
Ran Nussbaum
8 Sep 16
4
S DONALD SUSSMAN
8 Sep 16
SC 13D
Arno Therapeutics, Inc
8 Sep 16
SC 13D
Arno Therapeutics, Inc
8 Sep 16
SC 13D
Arno Therapeutics, Inc
8 Sep 16
SC 13G/A
Arno Therapeutics, Inc
22 Aug 16
4
Arie Belldegrun
17 Aug 16
4
Tomer Kariv
17 Aug 16
4/A
Tomer Kariv
15 Apr 16
4
DAVID M TANEN
11 Apr 16
4
WILLIAM F PHD HAMILTON
11 Apr 16
4
Alexander A Zukiwski
11 Apr 16
4
Tomer Kariv
11 Apr 16
4
Stefan Proniuk
11 Apr 16
4
Steven B Ruchefsky
11 Apr 16
4
Arie Belldegrun
11 Apr 16
4
Yacov Reizman
11 Apr 16
SC 13G/A
Arno Therapeutics, Inc
16 Feb 16
3
Jay Moorin
14 Jan 16
4
Jay Moorin
14 Jan 16
4
Steven B Ruchefsky
14 Jan 16
4
Alexander A Zukiwski
14 Jan 16
4
Arie Belldegrun
14 Jan 16
4
Tomer Kariv
14 Jan 16
4
DAVID M TANEN
14 Jan 16
SC 13G/A
Arno Therapeutics, Inc
5 Jan 16
4
Steven B Ruchefsky
6 Nov 15
SC 13G
Arno Therapeutics, Inc
17 Feb 15
SC 13G/A
Arno Therapeutics, Inc
13 Feb 15